3:34 PM
 | 
May 15, 2018
 |  BC Extra  |  Financial News

Imprimis spinout Surface raises $20M series A

Eye disease company Surface Pharmaceuticals Inc. (Pleasanton, Calif.) launched with a $20 million series A round funded by an investment entity managed by Flying L Partners. Surface is a spinout from drug delivery company and compounding pharmacy Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY), which retains about a 30%...

Read the full 210 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >